Technical Analysis for 0DPB - Bavarian Nordic A/S
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | -2.03% | |
Bollinger Band Squeeze | Range Contraction | -2.03% | |
Narrow Range Bar | Range Contraction | -2.03% | |
Doji - Bullish? | Reversal | -2.03% | |
Fell Below 20 DMA | Bearish | -3.07% | |
180 Bearish Setup | Bearish Swing Setup | -3.07% | |
Bollinger Band Squeeze | Range Contraction | -3.07% |
Free Daily (Stock) Chart Reading
Bavarian Nordic A/S Description
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Classification
Keywords: Drugs Smallpox Vaccination Vaccines
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 267.6 |
52 Week Low | 126.7 |
Average Volume | 8,090 |
200-Day Moving Average | 181.22 |
50-Day Moving Average | 161.86 |
20-Day Moving Average | 156.76 |
10-Day Moving Average | 158.72 |
Average True Range | 15.31 |
RSI (14) | 41.86 |
ADX | 55.19 |
+DI | 7.65 |
-DI | 4.28 |
Chandelier Exit (Long, 3 ATRs) | 127.38 |
Chandelier Exit (Short, 3 ATRs) | 176.79 |
Upper Bollinger Bands | 167.05 |
Lower Bollinger Band | 146.47 |
Percent B (%b) | 0.21 |
BandWidth | 13.13 |
MACD Line | -1.53 |
MACD Signal Line | -1.01 |
MACD Histogram | -0.5213 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 159.43 | ||||
Resistance 3 (R3) | 160.38 | 158.47 | 157.99 | ||
Resistance 2 (R2) | 158.47 | 156.27 | 157.99 | 157.51 | |
Resistance 1 (R1) | 154.63 | 154.91 | 153.68 | 153.68 | 157.03 |
Pivot Point | 152.72 | 152.72 | 152.24 | 152.24 | 152.72 |
Support 1 (S1) | 148.88 | 150.52 | 147.93 | 147.93 | 144.57 |
Support 2 (S2) | 146.97 | 149.16 | 146.49 | 144.09 | |
Support 3 (S3) | 143.13 | 146.97 | 143.61 | ||
Support 4 (S4) | 142.18 |